CSIMarket
 


Abbott Laboratories  (ABT)
Other Ticker:  
 
 

ABT's Free Cash Flow Growth by Quarter and Year

Abbott Laboratories's Free Cash Flow results by quarter and year




ABT Free Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 3,798.00 2,416.00 1,765.00
III Quarter September - 2,066.00 1,948.00 2,183.00
II Quarter June - 1,322.00 1,060.00 1,244.00
I Quarter March 2,637.00 715.00 712.00 1,108.00
FY   2,637.00 7,901.00 6,136.00 6,300.00



ABT Free Cash Flow first quarter 2021 Y/Y Growth Comment
Abbott Laboratories achieved in the first quarter, above Company average Free Cash Flow surge of 268.81% year on year, to $ 2,637.00 millions.

Looking into first quarter results within Major Pharmaceutical Preparations industry 9 other companies have achieved higher Free Cash Flow growth. While Abbott Laboratories' s Free Cash Flow doubling of 268.81% ranks overall at the positon no. 402 in the first quarter.




ABT Free Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 57.2 % 36.88 % 7.62 %
III Quarter September - 6.06 % -10.77 % 8.88 %
II Quarter June - 24.72 % -14.79 % -7.92 %
I Quarter March 268.81 % 0.42 % -35.74 % 93.03 %
FY   - 28.76 % -2.6 % 13.11 %

Financial Statements
Abbott Laboratories's first quarter 2021 Free Cash Flow $ 2,637.00 millions ABT's Income Statement
Abbott Laboratories's first quarter 2020 Free Cash Flow $ 715.00 millions Quarterly ABT's Income Statement
New: More ABT's historic Free Cash Flow Growth >>


ABT Free Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 83.83 % 24.02 % -19.15 %
III Quarter September - 56.28 % 83.77 % 75.48 %
II Quarter June - 84.9 % 48.88 % 12.27 %
I Quarter March -30.57 % -70.41 % -59.66 % -32.44 %
FY (Year on Year)   - 28.76 % -2.6 % 13.11 %




Free Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #40
Overall #402

Free Cash Flow Y/Y Growth Statistics
High Average Low
29.62 % 2.06 % -58.14 %
(Sep. 30, 2014)   (Sep. 30, 2013)
Free Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #40
Overall #402
Free Cash Flow Y/Y Growth Statistics
High Average Low
29.62 % 2.06 % -58.14 %
(Sep. 30, 2014)   (Sep. 30, 2013)

Free Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Abbott Laboratories's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
802.06 % 57.06 % -100 %
(June 30. 2005)  


ABT's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2021 Abbott Laboratories reported fall in Free Cash Flow from the forth quarter by -30.57% to $ 2,637.00 millions, from $ 3,798.00 millions released in the previous reporting period.

If you evaluate current downturn in the I. Quarter 2021, you must presume, that usually I. Quarter 2021 results emerge softer then in the preciding period

Within Major Pharmaceutical Preparations industry 20 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Abbott Laboratories's Free Cash Flow growth quarter on quarter, overall rank is 845.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #21
Healthcare Sector #61
Overall #845
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #21
Healthcare Sector #61
Overall #845
Free Cash Flow Q/Q Growth Statistics
High Average Low
802.06 % 57.06 % -100 %
(June 30. 2005)  


ABT's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2021 Abbott Laboratories reported fall in Free Cash Flow from the forth quarter by -30.57% to $ 2,637.00 millions, from $ 3,798.00 millions released in the previous quarter.

If you analyse current shortcoming in the quarter, you suppose to take into consideration, that frequently I. Quarter Free Cash Flow occur weaker in contrast to the preciding period

Within Major Pharmaceutical Preparations industry 20 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Abbott Laboratories's Free Cash Flow growth quarter on quarter, overall rank is 845.


Abbott Laboratories's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Free Cash Flow 12 Months Ending $ 12,037.00 $ 10,078.00 $ 8,451.00 $ 8,238.00 $ 7,802.00
Y / Y Free Cash Flow Growth (TTM) 54.28 % 29.64 % 18.1 % 12.17 % 6.03 %
Year on Year Free Cash Flow Growth Overall Ranking # 377 # 793 # 986 # 986 # 235
Seqeuential Free Cash Flow Change (TTM) 19.44 % 19.25 % 2.59 % 5.59 % 0.36 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 402 # 559 # 641 # 718 # 239




Cumulative Free Cash Flow growth Comment
Abbott Laboratories saw improvement in Free Cash Flow growth trend, posting cumulative 12 months Free Cash Flow growth of 54.28% year on year, to $ 12,037 millions if the fiscal year would have ended in Mar 31 2021.
Abbott Laboratories's trailing twelve months Free Cash Flow growth was higher than company's average 11.68% and higher than 29.64% growth in Dec 31 2020.
But from twelve months ended Dec 31 2020 rise was slower at 19.44 % from $10078 millions reported in twelve months ending a quarter before.
In spite of, it was evidence of strength, while the typical sequential Free Cash Flow advancement lays at 2.06%.
The momentum was even stronger sequentially showed at 19.44 % increase from $10078 millions in twelve months ending a quarter before.

In the Healthcare sector 48 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 377, from total ranking in previous quarter at 793.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
29.62 %
2.06 %
-58.14 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 10
Healthcare Sector # 49
Overall # 377

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
58.76 %
11.68 %
-65.04 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 40
S&P 500 # 402
Cumulative Free Cash Flow growth Comment
Abbott Laboratories saw improvement in Free Cash Flow growth trend, posting cumulative 12 months Free Cash Flow growth of 54.28% year on year, to $ 12,037 millions if the fiscal year would have ended in Mar 31 2021.
Abbott Laboratories's trailing twelve months Free Cash Flow growth was higher than company's average 11.68% and higher than 29.64% growth in Dec 31 2020.
But from the previous reporting period rise was beneth at 19.44 % from $10078 millions recorded in the period from Dec 31 2020 to Mar 31 2020 Melker Andersson went on.
Still this was confirmation of convincing trend, as the usual Q/Q TTM growth lays at 2.06%.
The momentum was much more impressive sequentially clinched at 19.44 % rise from $10078 millions in twelve months ending a quarter before.

In the Healthcare sector 48 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 377, from total ranking in previous quarter at 793.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
29.62 %
2.06 %
-58.14 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 10
Healthcare Sector # 49
Overall # 377

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
58.76 %
11.68 %
-65.04 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 40
S&P 500 # 402




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
ABT's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for ABT's Competitors
Free Cash Flow Growth for Abbott Laboratories's Suppliers
Free Cash Flow Growth for ABT's Customers

You may also want to know
ABT's Annual Growth Rates ABT's Profitability Ratios ABT's Asset Turnover Ratio ABT's Dividend Growth
ABT's Roe ABT's Valuation Ratios ABT's Financial Strength Ratios ABT's Dividend Payout Ratio
ABT's Roa ABT's Inventory Turnover Ratio ABT's Growth Rates ABT's Dividend Comparisons



Companies with similar Free Cash Flow fall for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Mar 31 2021
Laboratory Corporation Of America Holdings468.01%$ 468.008 millions
Select Medical Holdings Corp444.16%$ 444.161 millions
Encompass Health Corporation440.96%$ 440.956 millions
Iqvia Holdings Inc 431.90%$ 431.902 millions
Inogen Inc 429.63%$ 429.630 millions
Elanco Animal Health Inc411.63%$ 411.628 millions
Lemaitre Vascular Inc410.85%$ 410.849 millions
Infusystem Holdings Inc375.94%$ 375.943 millions
Hologic Inc369.16%$ 369.159 millions
Axon Enterprise inc 354.26%$ 354.260 millions
Idexx Laboratories Inc346.42%$ 346.421 millions
Eli Lilly And Company343.88%$ 343.881 millions
Myriad Genetics Inc 327.38%$ 327.381 millions
Tenet Healthcare Corp313.95%$ 313.953 millions
Supernus Pharmaceuticals inc 306.01%$ 306.012 millions
Endo International Plc289.79%$ 289.795 millions
Abbott Laboratories268.81%$ 268.811 millions
Msa Safety Inc235.24%$ 235.239 millions
Integra Lifesciences Holdings Corp231.90%$ 231.897 millions
Eagle Pharmaceuticals inc 231.79%$ 231.792 millions
Pra Health Sciences Inc 217.26%$ 217.264 millions
Amneal Pharmaceuticals Inc 202.14%$ 202.142 millions
Quest Diagnostics Inc195.95%$ 195.951 millions
Mallinckrodt Plc181.94%$ 181.937 millions
Bruker Corporation180.00%$ 180.000 millions
Five Star Senior Living Inc 173.87%$ 173.874 millions
National Research Corporation160.87%$ 160.873 millions
Merck and Co Inc 153.32%$ 153.324 millions
Charles River Laboratories International inc 148.18%$ 148.183 millions
Becton Dickinson And Company145.96%$ 145.963 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GLP's Profile

Stock Price

GLP's Financials

Business Description

Fundamentals

Charts & Quotes

GLP's News

Suppliers

GLP's Competitors

Customers & Markets

Economic Indicators

GLP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071